Literature DB >> 10746501

Comparison of three methods for identification of Streptococcus milleri group isolates to species level.

A Limia1, T Alarcón, M L Jiménez, M López-Brea.   

Abstract

A collection of 180 clinical isolates of Streptococcus milleri group were identified to species level using two phenotypic methods (a commercial system and the reference method based on differential phenotypic reactions) and a genotypic method (hybridisation of the 16S rRNA gene with species-specific probes) in order to evaluate the performance of the respective methods. A high level of agreement (80%) was observed between the results of the reference method and the genotypic method. The highest level of agreement was found for the species Streptococcus anginosus (83%), a high level of agreement (76%) also being achieved for Streptococcus constellatus and Streptococcus intermedius. The sensitivity of the commercial system compared to the genotypic method was 76% overall, but it was low (57.5%) for Streptococcus intermedius. Twenty-five strains belonged to the recently described CI strains.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10746501     DOI: 10.1007/s100960050444

Source DB:  PubMed          Journal:  Eur J Clin Microbiol Infect Dis        ISSN: 0934-9723            Impact factor:   3.267


  11 in total

1.  Identification of clinically relevant viridans group streptococci by phenotypic and genotypic analysis.

Authors:  C Teles; A Smith; G Ramage; S Lang
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2010-10-28       Impact factor: 3.267

2.  Comparing Matrix-Assisted Laser Desorption Ionization-Time of Flight Mass Spectrometry and Phenotypic and Molecular Methods for Identification of Species within the Streptococcus anginosus Group.

Authors:  Raquel Arinto-Garcia; Marcos Daniel Pinho; João André Carriço; José Melo-Cristino; Mário Ramirez
Journal:  J Clin Microbiol       Date:  2015-09-09       Impact factor: 5.948

3.  Species-level molecular identification of invasive "Streptococcus milleri" group clinical isolates by nucleic acid sequencing in a centralized regional microbiology laboratory.

Authors:  Peter Daley; Deirdre L Church; Daniel B Gregson; Sameer Elsayed
Journal:  J Clin Microbiol       Date:  2005-06       Impact factor: 5.948

4.  Identification of clinically relevant viridans streptococci by an oligonucleotide array.

Authors:  Chao Chien Chen; Lee Jene Teng; Seng Kaiung; Tsung Chain Chang
Journal:  J Clin Microbiol       Date:  2005-04       Impact factor: 5.948

5.  Antibiotic susceptibilities of genetically characterized Streptococcus milleri group strains.

Authors:  M Tracy; A Wanahita; Y Shuhatovich; E A Goldsmith; J E Clarridge; D M Musher
Journal:  Antimicrob Agents Chemother       Date:  2001-05       Impact factor: 5.191

6.  Development of real-time PCR assays for detection of the Streptococcus milleri group from cystic fibrosis clinical specimens by targeting the cpn60 and 16S rRNA genes.

Authors:  A B Olson; C D Sibley; L Schmidt; M A Wilcox; M G Surette; C R Corbett
Journal:  J Clin Microbiol       Date:  2010-02-17       Impact factor: 5.948

7.  Characterization of Streptococcus milleri group isolates from expectorated sputum of adult patients with cystic fibrosis.

Authors:  Margot E Grinwis; Christopher D Sibley; Michael D Parkins; Christina S Eshaghurshan; Harvey R Rabin; Michael G Surette
Journal:  J Clin Microbiol       Date:  2009-12-09       Impact factor: 5.948

Review 8.  What happened to the streptococci: overview of taxonomic and nomenclature changes.

Authors:  Richard Facklam
Journal:  Clin Microbiol Rev       Date:  2002-10       Impact factor: 26.132

9.  Evaluation of genotypic and phenotypic methods for differentiation of the members of the Anginosus group streptococci.

Authors:  P H Summanen; M-C Rowlinson; J Wooton; S M Finegold
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2009-06-04       Impact factor: 3.267

Review 10.  Streptococcus intermedius causing infective endocarditis and abscesses: a report of three cases and review of the literature.

Authors:  MaryAnn P Tran; Molly Caldwell-McMillan; Walid Khalife; Vincent B Young
Journal:  BMC Infect Dis       Date:  2008-11-10       Impact factor: 3.090

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.